Patients were randomly assigned ( @:@ ) with an interactive voice and web response system to receive either @ mg everolimus once a day orally or placebo plus weekly trastuzumab intravenously at @ mg/kg loading dose on day @ with subsequent weekly doses of @ mg/kg of each @ week cycle plus paclitaxel intravenously at a dose of @ mg/m ( @ ) on days @ , @ , and @ of each @ week cycle .